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1. Introduction 
Most of the studies of the regulation of gluconeo- 
genesis in mammalian liver have been carried out us- 
ing the rat and have pointed to a key role for the en- 
zyme P-enolpyruvate carboxykinase (E C 4. 1. 1. 2) 
[l-3]. In this species the hepatic enzyme is almost 
totally cytosolic and is induced by a variety of dietary 
and hormonal affecters [4-71. More recently, work 
with other species such as the guinea pig [2,8,9], 
rabbit [lo] and cat [ 1 l] , all of which contain SO-60% 
of their total P-enolpyruvate in the mitochondria, has 
indicated that the regulation of hepatic gluconeogenesis 
in these animals may be different from that in rat liver. 
The mitochondrial formation of P-enolpyruvate is of 
considerable importance in gluconeogenesis in guinea 
pig and rabbit liver [ 121 and is markedly decreased by 
both fatty acids and fi-hydroxybutyrate which act by 
increasing mitochondrial NADH levels [9, IO]. These 
compounds also inhibit gluconeogenesis from lactate 
and alanine in the isolated, perfused liver from both 
species and stimulates it in rat liver [8, 13- 151. The 
difference in the regulation of glucose synthesis in 
guinea pig and rabbit liver as compared to rat liver 
underlines the difficulties in generalizing about the 
control of important metabolic processes between spe- 
cies. This is of critical importance since human liver 
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contains 60% of its total P-enolpyruvate carboxy- 
kinase in the mitochondria. In the present paper we 
have assessed the capacity of human liver mitochon- 
dria to synthesize P-enolpyruvate as well as the ef- 
fect of fatty acids in this process. 
2. Methods 
Guinea pig or human liver mitochondria were iso- 
lated by differential centrifugation in 0.32 M sucrose 
and 2 mM HEPESt buffer at pH 7.35. After sedimen- 
tation of the nuclear pellet, the mitochondria were 
extracted and then washed twice with the sucrose- 
HEPES buffer. Oxygen consumption and ADP phos- 
phorylation were simultaneously monitored with a 
Clark type oxygen electrode and Radiometer com- 
bination glass electrode with subsequent amplification 
of the resulting signal. 
Approx. 12 mg of mitochondrial protein was incu- 
bated in 3 ml of medium and the metabolites deter- 
mined after stopping the incubation with 36% perch- 
loric acid. The extracts were chilled to 0” and neutral- 
ized with KHCO,. Mitochondrial proteins were mea- 
sured by ultraviolet absorption using serum albumin 
as a standard [ 161. Analysis of ATP [ 171, ADP and 
AMP [ 181, P-enolpyruvate [ 191, malate [20] and (Y- 
ketoglutarate [21] were performed by standard en- 
zymatic methods. 
3. Results 
In fig. 1 are shown results obtained with simulta- 
neous monitoring of proton movements and oxygen 
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Fig. 1. Oxygen consumption and proton movement by mito- 
chondrial suspensions from human liver. 2 mg of mitochon- 
drial protein were incubated at 25” in 0.8 ml of 0.25 M su- 
crose containing 5 mM MgCl2, 1.6 mM HEPES, 5 mM potassium 
phosphate, 5 mM malate, 5 mM glutamate at pH 7.5. At times 
shown by the arrows 0.15 mM ADP, twice 1.25 PM rotenone, 
6.25 mM succinate and 0.15 UM ADP were added. 
consumption during oxidation of malate + glutamate 
by human liver mitochondria. A net state 3 - state 4 
transition was noticed, with a respiratory control ratio 
of about 3 and a calculated P/O ratio of 2.5. Also, the 
ratio of oxygen consumption in state 42 to state 4, 
was very close to 1, indicating negligible ATPase activi- 
ty, as shown by the traces of proton movement. Respi- 
[H+l 4
Oxygen Consumption 
Fig. 2. Oxygen consumption and proton movement by mit- 
ochondrial suspensions from human liver. 2 mg of mitochon- 
drial protein were incubated in conditions similar to those 
described under fig. 1. At times shown by the arrows, 0.15 
mM ADP and 0.14 PM FCCP were added. 
ration by isolated human liver mitochondria was 
blocked by rotenone, an inhibitor of the electron 
transport chain at site I, while further additions of 
succinate and ADP produced oxidative hosphory- 
lation with a P/O ratio of 1.7. FCCP ad 
% 
ition pro- 
duced a typical acceleration of oxygen onsumption 
with a marked proton release due to the uncoupling 
effect (fig. 2). 
Table 1 
Influence of fatty acids on the metabolism of human and guinea pig liver mitochondria. 
Substrate Octanoate PEP ATP AMP ADP Malate a-Ketoglutarate 
(0.2 mM) (nmoles produced/mg protein) (nmoles used/mg protein) 
Human Malate _ 
+ 
or-Ketoglutarate - 
+ 
64 476 50 468 525 
23 523 36 544 572 
44 549 38 511 192 
21 549 26 571 206 
Guinea Malate _ 66 * 5.6 344 f 21 31 r 2.3 423 + 12 346 fr 30 
Pig + 35 + 1.9 416520 33 t 7.4 462 f 25 362 + 36 
a-Ketoglutarate - 42 f 1.8 387 * 25 35 f 5.0 447 f 13 221 + 26 
+ 19 + 1.2 398 f 23 29 f 5.6 453 +6 233 f 25 
Approx. 12 mg of mitochondrial protein were incubated for 10 min at 30” in 3 ml of 160 mM sucrose,1 mM HEPES, 20 mM po- 
tassium phosphate at pH 7.5, 6.6 mM MgC12, 3.3 mM ADP and either 5 mM malate or 5 mM or-ketoglutarate. Values are the 
means t standard error for 5 experiments with guinea pigs and the result obtained from the human sample. 
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Table 1 illustrates a comparison between human 
and guinea pig intramitochondrial P-enolpyruvate for- 
mation and the influence of octanoate on the meta- 
bolism of these mitochondria oxidizing malate or (Y- 
ketoglutarate. A striking similarity between the two 
species was noticed in their capacity for synthesizing 
P-enolpyruvate and ATP. The rate of utilization of 
malate, a-ketoglutarate and ADP was similar for liver 
mitochondria from both species. In presence of 0.2 
mM octanoate, both human and guinea pig liver mit- 
ochondria synthesized much less P-enolpyruvate from 
malate or o-ketoglutarate, while the rate of ATP for- 
mation was not significantly affected. The observed 
ATP synthesis was not due to an adenylate kinase 
(EC 2. 7.4. 3) since no enhancement of AMP pro- 
duction was observed in the presence of octanoate. 
Finally, the rate of utilization of malate, cw-ketogluta- 
rate or ADP was not significantly affected by the ad- 
dition of this fatty acid. 
4. Discussion 
The results of the present study indicate a similarity 
in the mechanism which regulates mitochondrial P- 
enolpyruvate formation in human and guinea pig liver. 
This is of particular importance since it supports a 
more general model for the regulation of gluconeo- 
genesis suggested by studies of perfused guinea pig 
and rabbit livers [ 141. As was first demonstrated by 
Willms and Soling [8, 131, fatty acids inhibit gluco- 
neogenesis in perfused guinea pig liver while stimulating 
this process in the rat. Garber and Hanson [9] made 
the assumption that the presence of mitochondrial 
P-enolpyruvate carboxykinase in guinea pig liver mit- 
ochondria could contribute to the differences in fatty 
acid effects on gluconeogenesis noted by Soling and 
Willms [8]. In studies of P-enolpyruvate formation by 
isolated guinea pig liver mitochondria, we noted that 
the rate of P-enolpyruvate formation from a variety 
of substrates could be inhibited by shifting the mit- 
ochondrial NAD/NADH ratio more reduced. The sig 
nificance of this factor was underlined by the obser- 
vation that freeze-clamped guinea pig liver has a nor- 
mal mitochondrial NAD/NADH ratio of 13 which 
shifts markedly oxidized (to 33) after 48 hr of star- 
vation [9]. In our view, the mechanism for the inhib- 
ition of glucose formation by guinea pig liver caused 
by fatty acids was an increased mitochondrial NADH 
concentration caused by fatty acid oxidation. To sup- 
port this idea, Arinze et al. [ 141 have shown that 
fl-hydroxybutyrate infusion into guinea pig, rabbit 
and cat liver (all species containing the bulk of this 
total hepatic P-enolpyruvate carboxykinase in the 
mitochondria) reduces gluconeogenesis. 
If the hypothesis discussed above is correct, then 
it might also be applicable to the regulation of glu- 
coneogenesis in human liver. As a first step toward 
testing this possibility we have isolated human liver 
mitochondria and studied the control of P-enolpyru- 
vate formation by fatty acids. The results of these 
studies, presented in this paper, indicate an almost 
identical response to fatty acids by mitochondria from 
both human and guinea pig liver. It remains to be de- 
termined whether these mitochondrial studies can be 
directly applied to human liver and if fatty acids in- 
hibits hepatic gluconeogenesis in the human. How- 
ever, the guinea pig would seem to be a better model 
than the rat for studies of the regulation of gluconeo- 
genesis in human liver. 
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